Latest Headlines

Latest Headlines

Abbott's diabetes biz hit with its third Class I recall in a year

Add two more Abbott Laboratories diabetes products to the list of items deemed potentially deadly by the FDA. Five of the company's diabetes offerings have now been subject to the agency's most serious recall label in the past year.

Yes, U.S. med tech recalls have doubled since 2003--but so has the market

"Medical device recalls nearly doubled in a decade," proclaims The Wall Street Journal 's headline--a bit of data the FDA is expected to release Friday that seems likely to travel far on social media. Critics are already making hay, questioning the rigor of pre-market vetting at the FDA.

Word of a $16M Coloplast vaginal-mesh settlement spurs global resolution talk

Danish medical device maker Coloplast is said to have paid $16 million to settle lawsuits claiming it injured women with vaginal-mesh inserts. With settlement talk swirling around at least 5 more makers of the plagued devices, that has some watchers saying the time may be ripe for a global settlement.

J&J gets good news in vaginal mesh suit

Johnson & Johnson's Ethicon division won big in an ongoing suit regarding its vaginal mesh implants: After one week of testimony, a federal district judge in Charleston, WV, ruled that the company's pelvic mesh product did not cause injury.

Teleflex triggered a global recall for a tracheal tube that can crease during use

A Teleflex subsidiary is voluntarily recalling one of its tracheal tubes because of reports that it can kink during use and cut off a patient's air supply. The FDA slapped its Class I recall designation on the Pennsylvania company's action, meaning the defect carries with it a risk of major injury or death.

Tandem expands its voluntary recall of the t:slim insulin pump

Tandem Diabetes Care is expanding a voluntary recall of specific lots of insulin cartridges used with its t:slim insulin pump. The cartridges may be at risk of leaking, resulting in over- or under-doses of insulin.

FDA slaps its most serious label on Abbott's diabetes recall

Abbott Laboratories is in the midst of a voluntary recall of some test strips for its blood glucose meters, and now the FDA is warning that use of the faulty products could lead to serious injury or death.

Nipro is recalling glucose meters over a display mixup

Japanese giant Nipro Diagnostics is pulling some of its glucose meters off the shelf over a unit-of-measure error that could lead customers to misread them and misunderstand blood sugar levels.

Intuitive Surgical's robot surgery injuries went unreported for years, report says

Dozens of injuries involving Intuitive Surgical's ($ISRG) da Vinci surgical robots went unreported to the FDA for years or were missing from the agency's database entirely, though they subsequently cropped up in legal documents or after interviews with patients,  Bloomberg  has found.

Report: Insurers could gain up to $1B in J&J hip settlement deal

Insurers also stand to gain plenty from Johnson & Johnson's $2.5 billion-plus offer to settle 8,000 lawsuits involving faulty metal hip implants. Bloomberg reported that the conglomerate will fork over as much as $1 billion to insurers who covered patients' cost of removing the now-recalled ASR implants.